Brave new world? Arrestin pathway bias in drug design.

MLA

Andresen, Bradley T., and Louis M. Luttrell. “Brave New World? Arrestin Pathway Bias in Drug Design.” Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 11, no. 2, June 2011, pp. 90–91. EBSCOhost, https://doi.org/10.2174/187153011795564142.

APA

Andresen, B. T., & Luttrell, L. M. (2011). Brave new world? Arrestin pathway bias in drug design. Endocrine, Metabolic & Immune Disorders Drug Targets, 11(2), 90–91. https://doi.org/10.2174/187153011795564142

Chicago

Andresen, Bradley T, and Louis M Luttrell. 2011. “Brave New World? Arrestin Pathway Bias in Drug Design.” Endocrine, Metabolic & Immune Disorders Drug Targets 11 (2): 90–91. doi:10.2174/187153011795564142.